Pharmaceuticals & Life Sciences
Pain Points
Temperature excursions during transit compromise drug efficacy and patient safety. Manual chain-of-custody documentation creates audit vulnerabilities. Counterfeit pharmaceuticals infiltrate supply chains through unverified handoffs.
Solution
Continuous temperature, humidity, and light exposure monitoring with automated excursion alerts. FDA 21 CFR Part 11-compliant electronic records with cryptographic signatures. GDP-aligned cold chain verification with blockchain-anchored audit trails. Real-time visibility into shipment location and condition throughout distribution networks.
Compliance Standards
FDA 21 CFR Part 11, EU GDP (Good Distribution Practice), DSCSA (Drug Supply Chain Security Act), WHO GDP Guidelines